Bryn Inc. reported a first quarter 2026 net loss of $(30,937) and diluted earnings per share of $(0.00), reflecting a wider loss versus the year‑ago quarter when net loss was $(16,410) and diluted EPS was $(0.00).
Financial Highlights
- Net income: $(30,937) for 1Q 2026, versus $(16,410) in 1Q 2025 (widened loss YoY).
- Diluted EPS: $(0.00) for 1Q 2026, versus $(0.00) in 1Q 2025.
Business Highlights
- Acquisition and ownership change: MEDO Healthcare acquired 10 million Series A‑1 shares, initiating a change in control and strategic direction.
- Rebranding and strategy shift: The company plans a name change to MEDO Technologies and intends to focus on AI‑driven optimization for pharmaceutical distribution.
- Targeted growth plan: Management aims to acquire nationwide pharmaceutical distributors and integrate AI across retail, mail‑order, and SNF/ALF verticals.
- Near‑term constraints: Operations are limited and working capital is insufficient; planned acquisitions and AI rollout are contingent on new capital and partner transactions.
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.